MOORE CAPITAL MANAGEMENT, LP - ACUMEN PHARMACEUTICALS INC ownership

ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 66 filers reported holding ACUMEN PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
MOORE CAPITAL MANAGEMENT, LP ownership history of ACUMEN PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$148,921
-96.5%
27,578
-93.5%
0.00%
-96.0%
Q3 2022$4,242,000
+151.8%
422,902
+18.0%
0.10%
+122.2%
Q2 2022$1,685,000
+20.2%
358,4820.0%0.04%
+25.0%
Q1 2022$1,402,000
-42.1%
358,4820.0%0.04%
-25.0%
Q4 2021$2,423,000
-55.9%
358,482
-3.0%
0.05%
-42.9%
Q3 2021$5,492,000369,5830.08%
Other shareholders
ACUMEN PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sands Capital Ventures, LLC 3,417,075$14,180,8614.20%
Knollwood Investment Advisory, LLC 1,628,510$6,758,3173.16%
Altium Capital Management LP 650,000$2,697,5001.41%
RA Capital Management 14,932,063$61,968,0611.22%
GREAT POINT PARTNERS LLC 1,074,101$4,457,5190.81%
Boxer Capital, LLC 2,206,983$9,158,9790.49%
Deep Track Capital, LP 2,513,044$10,429,1330.40%
Parkman Healthcare Partners LLC 499,814$2,074,2280.38%
Rock Springs Capital Management LP 2,812,579$11,672,2030.31%
Ghost Tree Capital, LLC 150,000$622,5000.20%
View complete list of ACUMEN PHARMACEUTICALS INC shareholders